Replies to post #78304 on $heff's $tation of $tocks & $olid DD

[pmony5]

ADMP long a bunch for the following catalysts. #1 Valuation is ridiculous 64 million dollars for a 9 drug pipeline is insane. #2 NDA for generic Epipen s/b out any day & generating revenues early 2015.#3 Generic Advair trials this summer & entering an untapped 6 + Billion dollar market. #4 possible partnerships this year. #5 After many conversations with ADMP imo I wouldn't be surprised to see ADMP spin off the Biotech side from the specialty generic side giving shareholders 2 companies for the price of current one which will unlock a much higher valuation. #6 Valuation lol I know already listed but deserves to be listed twice. Gotta also appreciate the large quick rise in Institutional ownership going from 1 or 2 holders in November to current 18 & garnering over 45% of total shares out plus Insiders owning almost 1 million shares leaving a very small float under 5 million shares. I think once this train gets going it will garner a quick ride higher imo. GLTA & make $$$$$$$$$$$$$$$$$$$$$$$$$$$